Navigation Links
Orthocare Innovations Receives Prestigious R&D 100 Award for Computerized Prosthesis Alignment System
Date:7/21/2009

OKLAHOMA CITY, July 21 /PRNewswire/ -- Orthocare Innovations and R&D Magazine have announced that Orthocare Innovations has been selected by R&D Magazine to receive the 2009 R&D 100 Award for its Computerized Prosthesis Alignment System, Compas(TM).

(Photo: http://www.newscom.com/cgi-bin/prnh/20090721/DA49239)

Compas(TM) represents a significant advance in the fitting and ongoing management of prosthetic device users. This new technology assists practitioners in achieving optimal alignment through objective feedback and analysis using embedded sensor technology. Compas(TM) marks a significant departure from traditional use of visual observation to align prosthetic devices, an approach that has been established through research as being highly subjective.

R&D 100 Awards salute the 100 most technologically significant products introduced into the marketplace over the past year. Products are selected by an independent judging panel and the editors of R&D Magazine. 2009 award recipients include Ford, Dow Chemical, Hitachi, Battelle and NASA. A full list of this year's winners is available at www.rdmag.com.

"The R&D 100 Awards honor the latest technology developments that are designed to meet societal, scientific, or business challenges facing us today--and tomorrow," said Rita Peters, editorial director of R&D Magazine.

"It is an honor to have been selected as a recipient of the R&D 100 Award, the most respected and highly coveted in the high-tech industry," added Orthocare Innovations CEO Doug McCormack. "Though we are an early-stage company, this recognition is testament to our world-class development team, led by Dr. David Boone, Orthocare Innovations' Chief Technology Officer. Compas(TM) was developed to address a long overlooked, but very real clinical challenge facing users of prosthetic devices. By improving prosthesis alignment, we are confident that we can significantly enhance clinical outcomes for patients worldwide."

Compas(TM) was developed with the support of the National Center for Medical Rehabilitation Research, National Institutes of Health, Grant Numbers R43HD047119 and R44HD047119.

About R&D 100

The winning of an R&D 100 Award provides a mark of excellence known to industry, government, and academia as proof that the product is one of the most innovative ideas of the year. This helps provide an important initial push a new product needs to compete successfully in the marketplace. Products are selected by an independent judging panel and the editors of R&D Magazine.

Since 1963, the R&D 100 Awards have identified revolutionary technologies newly introduced to the market. Many of these have become household names, helping shape everyday life for many Americans. These include the flashcube (1965), the automated teller machine (1973), the halogen lamp (1974), the fax machine (1975), the liquid crystal display (1980), the printer (1986), the Kodak Photo CD (1991), the Nicoderm antismoking patch (1992), Taxol anticancer drug (1993), lab on a chip (1996), and HDTV (1998).

About Orthocare Innovations

Orthocare Innovations is a medical device research and product development company that commercializes advanced technologies to improve clinical efficiency and to enhance the quality of patient care services in the prosthetic, orthotic and rehabilitative markets. Orthocare Innovations is based in Oklahoma City, with offices in Seattle and Washington, D.C. For more information, please visit orthocareinnovations.com.


'/>"/>
SOURCE Orthocare Innovations
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Johns Hopkins University Applied Physics Lab Group Joins OrthoCare Innovations
2. Young Innovations, Inc. Provides Second Quarter Conference Call Details
3. Echo Therapeutics To Present at Prestigious Innovations in Diabetes Conference
4. Mayo Clinic Center for Innovation to Sponsor a Collaborative Symposium on Innovations in Health Care Experience and Delivery
5. Confectionery Industry Forecast Is Sweet: Globally Inspired Flavors, Eco-Friendly and Health Minded Trends Lead New Product Innovations
6. BioInformatics, LLC New Report - Exploring the Epigenetics Market: Opportunities for Product Placement and Innovations
7. Clinical Innovations Introduces New Circumcision Device
8. Otix Global, Inc. to Become Parent Company of Sonic Innovations, Inc.
9. Inverness Medical Innovations Proposes to Acquire Concateno plc
10. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
11. FDAs Hydroxycut Recall Highlights the Need for Stem Cell Innovations ACTIVTox Human Liver Testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... IL (PRWEB) , ... February 28, 2017 , ... Today, ... ten years of saving lives by empowering young women to live proactively at a ... 1 in 75 will develop ovarian cancer. Prevention and early detection can save lives-but ...
(Date:2/28/2017)... ... February 28, 2017 , ... The ... America for the scientific development, healthcare training and clinical application of medical infrared ... Session on September 16-17 in Greenville, SC at the Bon Secours St. Francis ...
(Date:2/28/2017)... CA (PRWEB) , ... February 28, 2017 , ... ... Health Coach Institute (HCI) announced a new partnership through which HCI students, ... their coaching curriculum and practices. The partnership also enables the HCI community to ...
(Date:2/28/2017)... ... February 28, 2017 , ... In 2014, Harvard researchers published a report ... from prostate cancer, the researchers found that men who had undergone a vasectomy were ... prostate cancer. Although the increased risks are small, they seem to be contradicted by ...
(Date:2/28/2017)... ... ... Las Vegas Skin and Cancer Clinic (LVSCC) is proud to announce the ... pm PST. For more than six decades, LVSCC has provided the Las Vegas community ... been renovated to provide medical and cosmetic dermatological products and services. Patients at the ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... Calif. , Feb. 27, 2017  Titan ... therapeutics for the treatment of select chronic diseases ... today announced that the U.S. Food & Drug ... the ropinirole implant Investigational New Drug Application (IND) ... of the clinical study pending submission of the ...
(Date:2/28/2017)... and SAN FRANCISCO , February 27, 2017 ... Se D BioMedical ... of biotechnology assets   LOI contemplates capital infusion ... for building shareholder value   Amarantus names four new appointees ... Amarantus   SeD Biomedical Inc. (SeD ...
(Date:2/28/2017)... Feb. 27, 2017 Pulmonary drug delivery market ... from USD 36.10 billion in 2016, at a CAGR ... pulmonary route as an alternate route of drug delivery, ... increasing incidence of respiratory diseases such as COPD, asthma, ... growth during the forecast period. However, emerging markets and ...
Breaking Medicine Technology: